-
Mashup Score: 2Bluttropfen kann Leben retten: Babyscreening auf Krankheiten - 10 hour(s) ago
18. Dezember 2024, 6:00 Uhr Lesezeit: 4 Min. Ein Bluttropfen vom Fuß eines Babys genügt, um viele Krankheit zu erkennen. (Archivbild) (Foto: picture alliance / Stefan Sauer/dpa-Zentralbild/dpa) Mit einem Genomischen Neugeborenen-Screening könnten Babys auf Hunderte Krankheiten getestet werden. Forscher in Heidelberg und Mannheim arbeiten an einem flächendeckenden Konzept. Direkt aus dem dpa-Newskanal: Dieser Text wurde automatisch von der Deutschen Presse-Agentur (dpa) übernommen und von der SZ-Redaktion
Source: www.sueddeutsche.deCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0Heute ist Weltkindertag! - Hilfe für krebskranke Kinder Frankfurt - 3 month(s) ago
“Kranke Kinder haben Rechte“: Die Hessische Verfassung garantiert diese Rechte im Artikel 4 und stellt sicher, dass “bei allen Maßnahmen, die Kinder betreffen, das Wohl des Kindes ein wesentlich zu berücksichtigender Gesichtspunkt (ist)“. Zu diesem Thema hatten wir gemeinsam mit der Kinderhilfestiftung e.V. auf Einladung des Oberbürgermeisters Mike Josef im Frankfurter Kaisersaal eine Veranstaltung mit […]
Source: www.kinderkrebs-frankfurt.deCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 4
Since the late 1960s, virtually all newborns in Germany have been standardly tested for a number of rare but severe diseases, since a timely diagnosis and treatment of these diseases significantly improves their prognosis. Thousands of young patients have profited from Germany’s newborn screening program. In part, its success is also due to the program’s continued development, which led to the inclusion of further target diseases and new methods of analysis. The maturation of new genomic technologies now
Source: www.klinikum.uni-heidelberg.deCategories: General Medicine News, Oncologists1Tweet-
Our @BMBF_Bund project "NEW_LIVES: Genomic Newborn Screening Programs" now has a website! #gnbs If you'd like to learn more about the opportunities and challenges of using genome sequencing to diagnose and treat rare diseases in newborns👶, please visit: https://t.co/RwuUYzDkXL https://t.co/7yZlb84NWO
-
-
Mashup Score: 1Percentages and reasons: AI explainability and ultimate human responsibility within the medical field - 3 month(s) ago
Ethics and Information Technology – With regard to current debates on the ethical implementation of AI, especially two demands are linked: the call for explainability and for ultimate human…
Source: link.springer.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1Dynamic consent: a royal road to research consent? - 3 month(s) ago
In recent years, the principle of informed consent has come under significant pressure with the rise of biobanks and data infrastructures for medical research. Study-specific consent is unfeasible in the context of biobank and data infrastructure research; and while broad consent facilitates research, it has been criticised as being insufficient to secure a truly informed consent. Dynamic consent has been promoted as a promising alternative approach that could help patients and research participants regain control over the use of their biospecimen and health data in medical research. Critical voices have focused mainly on concerns around its implementation; but little has been said about the argument that dynamic consent is morally superior to broad consent as a way to respect people’s individual autonomy. In this paper, we identify two versions of this argument—an information-focused version and a control-focused version—and then argue that both fail to establish the moral superiority
Source: jme.bmj.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1
Das Nationale Centrum für Tumorerkrankungen (NCT) Heidelberg vereinigt Patientenversorgung, Krebsforschung und Krebsprävention unter einem Dach, um alle für den Kampf gegen Krebs relevanten Aspekte zu berücksichtigen.
Source: www.nct-heidelberg.deCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 5Ethics: Scientific Trends | OOIR - 3 month(s) ago
Research trends in Ethics, latest scientific publications, and journal rankings based on impact factor, h-index and other metrics.
Source: ooir.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0Could XAI harm patients in time-sensitive environments? - Journal of Medical Ethics blog - 4 month(s) ago
By Andreas Wabro. Achieving transparency and interpretability of algorithmic predictions remains an important research goal for many AI experts around the world. In particular, the epistemic benefits of explainable AI (XAI) methods have been widely discussed, and especially in the context of healthcare, international institutions and academic experts often call for measures to improve physicians’ […]Read More…
Source: blogs.bmj.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1When time is of the essence: ethical reconsideration of XAI in time-sensitive environments - 4 month(s) ago
The objective of explainable artificial intelligence systems designed for clinical decision support (XAI-CDSS) is to enhance physicians’ diagnostic performance, confidence and trust through the implementation of interpretable methods, thus providing for a superior epistemic positioning, a robust foundation for critical reflection and trustworthiness in times of heightened technological dependence. However, recent studies have revealed shortcomings in achieving these goals, questioning the widespread endorsement of XAI by medical professionals, ethicists and policy-makers alike. Based on a surgical use case, this article challenges generalising calls for XAI-CDSS and emphasises the significance of time-sensitive clinical environments which frequently preclude adequate consideration of system explanations. Therefore, XAI-CDSS may not be able to meet expectations of augmenting clinical decision-making in specific circumstances where time is of the essence. This article, by employing a pri
Source: jme.bmj.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 2
Driven by technological innovations, newborn screening (NBS) panels have been expanded and the development of genomic NBS pilot programs is rapidly progressing. Decisions on disease selection for NBS are still based on the Wilson and Jungner (WJ) criteria published in 1968. Despite this uniform reference, interpretation of the WJ criteria and actual disease selection for NBS programs are highly variable. A systematic literature search [PubMED search “Wilson” AND “Jungner”; last search 16.07.22] was performed to evaluate the applicability of the WJ criteria for current and future NBS programs and the need for adaptation. By at least two reviewers, 105 publications (systematic literature search, N = 77; manual search, N = 28) were screened for relevant content and, finally, 38 publications were evaluated. Limited by the study design of qualitative text analysis, no statistical evaluation was performed, but a structured collection of reported aspects of criticism and proposed improvements
Source: www.mdpi.comCategories: General Medicine News, Oncologists1Tweet
"Bluttropfen kann Leben retten: Babyscreening auf Krankheiten" #NEW_LIVES @SZ @cpschaaf https://t.co/9ueqoeuSYW